-
Something wrong with this record ?
The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC
V. Koucký, K. Hladíková, E. Táborská, J. Bouček, M. Grega, R. Špíšek, A. Fialová
Language English Country Germany
Document type Journal Article
Grant support
668217
Grantová Agentura, Univerzita Karlova
NLK
PubMed Central
from 1982
ProQuest Central
from 1997-03-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-04-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-03-01 to 1 year ago
Public Health Database (ProQuest)
from 1997-03-01 to 1 year ago
- MeSH
- Biomarkers MeSH
- Cytokines metabolism MeSH
- Dendritic Cells immunology metabolism pathology MeSH
- Squamous Cell Carcinoma of Head and Neck etiology metabolism pathology MeSH
- Gene Expression MeSH
- Papillomavirus Infections complications virology MeSH
- Interferon-alpha immunology metabolism MeSH
- Humans MeSH
- Disease Susceptibility MeSH
- Tumor Microenvironment * immunology MeSH
- T-Lymphocytes, Regulatory immunology metabolism MeSH
- Case-Control Studies MeSH
- T-Lymphocyte Subsets immunology metabolism MeSH
- Cell Transformation, Viral MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Plasmacytoid dendritic cells (pDCs) are the most potent type I interferon-producing cells and play an important role in antiviral immunity. Tumor-infiltrating pDCs were shown to be predominantly pro-tumorigenic, with reduced ability to produce interferon alpha (IFNα) and confirmed capacity to prime regulatory T cells (Tregs) by the ICOS/ICOS-L pathway. Because a significant number of HNSCCs are induced by human papillomaviruses and show markedly different immune profiles than non-virally induced tumors, we compared the phenotype and functional capacity of HNSCC-infiltrating pDCs to the HPV status of the tumor. We observed a reduced capacity of pDCs to produce IFNα upon toll-like receptor activation in HPV-negative samples and a rather uncompromised functionality in HPV-associated tumors. Additionally, supernatants from non-virally induced but not HPV-associated tumor cell suspensions significantly inhibited IFNα production by peripheral blood-derived pDCs. We identified IL-10 and TNFα as the soluble pDC-suppressive factors with the highest variability between HPV-negative and HPV-positive tumor-derived supernatants. Additionally, we observed a positive correlation of tumor-infiltrating pDCs with Tregs in HPV-negative samples but not in virally induced tumors. Overall, our study indicates that the immunosuppressive cytokine milieu rich in IL-10 and TNFα in HPV-negative but not in HPV-positive HNSCC significantly affects the functional capacity of tumor-infiltrating pDCs, and such dysfunctional pDCs may further support the immunosuppressive tumor microenvironment by promoting the expansion of Tregs in the tumor tissue.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024994
- 003
- CZ-PrNML
- 005
- 20220929144812.0
- 007
- ta
- 008
- 211013s2021 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00262-021-02874-y $2 doi
- 035 __
- $a (PubMed)33569630
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Koucký, Vladimír $u , Sotio, Prague, Czech Republic. koucky@sotio.com $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Motol University Hospital, Prague, Czech Republic. koucky@sotio.com
- 245 14
- $a The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC / $c V. Koucký, K. Hladíková, E. Táborská, J. Bouček, M. Grega, R. Špíšek, A. Fialová
- 520 9_
- $a Plasmacytoid dendritic cells (pDCs) are the most potent type I interferon-producing cells and play an important role in antiviral immunity. Tumor-infiltrating pDCs were shown to be predominantly pro-tumorigenic, with reduced ability to produce interferon alpha (IFNα) and confirmed capacity to prime regulatory T cells (Tregs) by the ICOS/ICOS-L pathway. Because a significant number of HNSCCs are induced by human papillomaviruses and show markedly different immune profiles than non-virally induced tumors, we compared the phenotype and functional capacity of HNSCC-infiltrating pDCs to the HPV status of the tumor. We observed a reduced capacity of pDCs to produce IFNα upon toll-like receptor activation in HPV-negative samples and a rather uncompromised functionality in HPV-associated tumors. Additionally, supernatants from non-virally induced but not HPV-associated tumor cell suspensions significantly inhibited IFNα production by peripheral blood-derived pDCs. We identified IL-10 and TNFα as the soluble pDC-suppressive factors with the highest variability between HPV-negative and HPV-positive tumor-derived supernatants. Additionally, we observed a positive correlation of tumor-infiltrating pDCs with Tregs in HPV-negative samples but not in virally induced tumors. Overall, our study indicates that the immunosuppressive cytokine milieu rich in IL-10 and TNFα in HPV-negative but not in HPV-positive HNSCC significantly affects the functional capacity of tumor-infiltrating pDCs, and such dysfunctional pDCs may further support the immunosuppressive tumor microenvironment by promoting the expansion of Tregs in the tumor tissue.
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a virová transformace buněk $7 D002472
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a dendritické buňky $x imunologie $x metabolismus $x patologie $7 D003713
- 650 _2
- $a náchylnost k nemoci $7 D004198
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interferon alfa $x imunologie $x metabolismus $7 D016898
- 650 _2
- $a infekce papilomavirem $x komplikace $x virologie $7 D030361
- 650 _2
- $a dlaždicobuněčné karcinomy hlavy a krku $x etiologie $x metabolismus $x patologie $7 D000077195
- 650 _2
- $a T-lymfocyty - podskupiny $x imunologie $x metabolismus $7 D016176
- 650 _2
- $a regulační T-lymfocyty $x imunologie $x metabolismus $7 D050378
- 650 12
- $a nádorové mikroprostředí $x imunologie $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hladíková, Kamila $u , Sotio, Prague, Czech Republic
- 700 1_
- $a Táborská, Eliška $u Sotio, Prague, Czech Republic $7 ola20211133478
- 700 1_
- $a Bouček, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Grega, Marek $u Department of Pathology and Molecular Medicine, Second Medical Faculty, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Špíšek, Radek $u , Sotio, Prague, Czech Republic
- 700 1_
- $a Fialová, Anna $u , Sotio, Prague, Czech Republic. fialova@sotio.com
- 773 0_
- $w MED00001041 $t Cancer immunology, immunotherapy : CII $x 1432-0851 $g Roč. 70, č. 9 (2021), s. 2545-2557
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33569630 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20220929144806 $b ABA008
- 999 __
- $a ok $b bmc $g 1714163 $s 1145501
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 70 $c 9 $d 2545-2557 $e 20210211 $i 1432-0851 $m Cancer immunology and immunotherapy $n Cancer Immunol Immunother $x MED00001041
- GRA __
- $a 668217 $p Grantová Agentura, Univerzita Karlova
- LZP __
- $a Pubmed-20211013